tiprankstipranks
Advertisement
Advertisement
Legend Biotech CEO Ying Huang steps down, Alan Bash named interim CEO
PremiumThe FlyLegend Biotech CEO Ying Huang steps down, Alan Bash named interim CEO
6d ago
Legend Biotech downgraded to Neutral from Buy at UBS
Premium
The Fly
Legend Biotech downgraded to Neutral from Buy at UBS
9d ago
Legend Biotech resumed with a Neutral at JPMorgan
Premium
The Fly
Legend Biotech resumed with a Neutral at JPMorgan
20d ago
Legend Biotech falls -12.2%
PremiumThe FlyLegend Biotech falls -12.2%
1M ago
Legend Biotech 7.7M share Spot Secondary priced at $29.35
Premium
The Fly
Legend Biotech 7.7M share Spot Secondary priced at $29.35
2M ago
Legend Biotech secondary offering; price range $29.35-$31.35
Premium
The Fly
Legend Biotech secondary offering; price range $29.35-$31.35
2M ago
Legend Biotech announces first clinical proof-of-concept data for LB2501
PremiumThe FlyLegend Biotech announces first clinical proof-of-concept data for LB2501
2M ago
Legend Biotech price target raised to $49 from $31 at UBS
Premium
The Fly
Legend Biotech price target raised to $49 from $31 at UBS
2M ago
Legend Biotech price target raised to $65 from $50 at H.C. Wainwright
Premium
The Fly
Legend Biotech price target raised to $65 from $50 at H.C. Wainwright
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100